News | March 28, 2024
Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
WINREVAIR is a breakthrough biologic for this rare, progressive disease
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Lonza plans to invest approximately CHF 500 million to upgrade the facility
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Additional capacity broadens Grace’s fine chemical capabilities for API production
Subscribe To Our Newsletter & Stay Updated
